City Therapeutics, Inc.

US$18.25As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CTYHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$908.1M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$21
17.48%
(93.88%)
Hold 3|2|2|10|0
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.25
0.25
0.28
0.26
(0.21%)
(2.40%)
10.92%
1.01%
Revenue$M
113.4
119.4
124.3
127.3
7.81%
12.37%
12.97%
11.41%
Peers (US$908.1M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.720
(0.192)
(0.178)
EBIT/Intx
2.111
0.173
0.151
Own earn%
(23.64)
18.17
23.29
Sh yield%
33.69
36.34
35.62
Owners
Insiders/Inst%
1.25
80.57
Short interest%
2.65
SBC / revenue%
5.96
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
1–6
$1 testx
—
Incr. ROIC%
12